The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-(N-(5-Cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)benzofuran-6-yl)methylsulfonamido)-2-fluorophenyl)boronic acid ID: ALA4548919
PubChem CID: 71263635
Max Phase: Preclinical
Molecular Formula: C26H23BF2N2O6S
Molecular Weight: 540.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(c3ccc(B(O)O)c(F)c3)S(C)(=O)=O)c(C3CC3)cc12
Standard InChI: InChI=1S/C26H23BF2N2O6S/c1-30-26(32)24-19-12-18(14-3-4-14)22(13-23(19)37-25(24)15-5-7-16(28)8-6-15)31(38(2,35)36)17-9-10-20(27(33)34)21(29)11-17/h5-14,33-34H,3-4H2,1-2H3,(H,30,32)
Standard InChI Key: ISLVVWCDXMALMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
14.8168 -4.3253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2295 -5.0352 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.6379 -4.3228 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6478 -4.2180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6467 -5.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3547 -5.4465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3529 -3.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0616 -4.2144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0618 -5.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8448 -5.2917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3285 -4.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8444 -3.9598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1424 -4.6239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5507 -5.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3671 -5.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7763 -4.6248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3631 -3.9149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5480 -3.9183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0966 -3.1826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8959 -3.0124 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1482 -2.2351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5496 -2.5755 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.5935 -4.6234 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.9380 -3.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5292 -3.0987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1208 -3.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9386 -5.4456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5232 -5.4444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9379 -6.2628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2277 -6.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2267 -7.4821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9346 -7.8921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6450 -7.4798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6425 -6.6647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3538 -7.8865 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.9349 -8.7093 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0
15.2274 -9.1182 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6428 -9.1176 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
11 13 1 0
12 19 1 0
19 20 1 0
20 21 1 0
19 22 2 0
16 23 1 0
25 24 1 0
26 25 1 0
24 26 1 0
4 24 1 0
5 27 1 0
27 2 1 0
2 28 1 0
27 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
33 35 1 0
32 36 1 0
36 37 1 0
36 38 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 540.35Molecular Weight (Monoisotopic): 540.1338AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. Chong PY, Shotwell JB, Miller J, Price DJ, Maynard A, Voitenleitner C, Mathis A, Williams S, Pouliot JJ, Creech K, Wang F, Fang J, Zhang H, Tai VW, Turner E, Kahler KM, Crosby R, Peat AJ.. (2019) Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV Inhibitor., 62 (7): [PMID:30763090 ] [10.1021/acs.jmedchem.8b01719 ]